IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,071,580 | -47.6% | 348,200 | -39.4% | 0.73% | -39.5% |
| Q2 2023 | $34,477,000 | -9.4% | 575,000 | -25.3% | 1.20% | -4.7% |
| Q1 2023 | $38,058,912 | -42.2% | 769,800 | -33.3% | 1.26% | -11.5% |
| Q4 2022 | $65,858,780 | -32.5% | 1,154,000 | -44.5% | 1.43% | -28.1% |
| Q3 2022 | $97,593,000 | +93.8% | 2,079,100 | +54.0% | 1.98% | +71.6% |
| Q2 2022 | $50,369,000 | +23.5% | 1,350,000 | -1.0% | 1.16% | +36.2% |
| Q1 2022 | $40,778,000 | -3.2% | 1,363,800 | +10.9% | 0.85% | -4.9% |
| Q4 2021 | $42,115,000 | +3.7% | 1,230,000 | +12.3% | 0.89% | -0.8% |
| Q3 2021 | $40,614,000 | +73.1% | 1,095,600 | +82.3% | 0.90% | +42.0% |
| Q2 2021 | $23,469,000 | +0.2% | 601,000 | +9.3% | 0.63% | -2.0% |
| Q1 2021 | $23,414,000 | – | 550,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |